Clinical Significance: Midazolam is a benzodiazepine used to treat insomnia and seizures.
Tested in urine only

Drug Class

Benzodiazepines

Metabolite(s)

None

Aliases

Dormonid

Methodology

Enzyme Immunoassay/Liquid Chromatography Mass Spectrometry

Urine Recommended Volume

30mL

Oral Fluid Minimum Volume

N/A

Specimen Stability

15 days

Urine Reportable Range

20-400

Oral Fluid Reportable Range

N/A

Urine Immunoassay Cutoff (ng/mL)

200

Urine Window of Detection

2-3 days

Oral Fluid Window of Detection

N/A

Rejection Criteria

Quantity Not Sufficient

Urine Transient Contanier

Urine Clinical Drug Test Transport Cup

Oral Fluid Transient Contanier

N/A